FLASH irradiations use dose-rates orders of magnitude higher than commonly used in
patient treatments. Such irradiations have shown interesting normal tissue sparing in cell …

Abstract 155 Tb [t 1/2= 5.32 d, E γ= 87 keV (32%); 105 keV (25%)(IAEA, 2021) is a novel
promising radionuclide for theranostic applications in nuclear medicine. Its physical …

Abstract 43 Sc and 44 Sc are positron emitter radionuclides that, in conjunction with the β−
emitter 47 Sc, represent one of the most promising possibilities for theranostics in nuclear …

Radiometals play a fundamental role in the development of personalized nuclear medicine.
In particular, copper radioisotopes are attracting increasing interest since they offer a varying …

A detector based on doped silica and optical fibers was developed to monitor the profile of
particle accelerator beams of intensity ranging from 1 pA to tens of μA. Scintillation light …

The availability of novel medical radionuclides is a key point in the development of
personalised nuclear medicine. In particular, copper radioisotopes are attracting …

A system for online measurement of the transverse beam emittance was developed. It is
named 4 PrOBεaM (4-Profiler Online Beam Emittance Measurement) and was conceived to …

The characterization of particle accelerator induced neutron fields is challenging but
fundamental for research and industrial activities, including radiation protection, neutron …

Abstract 44 Sc is a β+-emitter which has been extensively studied for nuclear medicine
applications. Its promising decay characteristics [t 1/2= 3.97 h, E β+= 632 keV (94.3%), E γ …

RadioNuclide Therapy (RNT) in nuclear medicine is a cancer treatment based on the
administration of radioactive substances that specifically target cancer cells in the patient …